Dr. Gebo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287Phone+1 410-955-1725- Is this information wrong?
Summary
- Dr. Kelly Gebo, MD, based out of Baltimore, MD, specializes in Infectious Disease with a subspecialty in HIV/AIDS Medicine. She completed her education and fellowships at Johns Hopkins University School of Medicine, where she obtained experience in areas such as HIV/AIDS, clinical research, vaccines, and highly active antiretroviral therapy, among others. Dr. Gebo has a range of publications, including research conducted on COVID-19 and HIV. She is a member of the American Society for Clinical Investigation and a fellow of the Infectious Diseases Society of America and American College of Physicians.
Education & Training
- Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2001
- Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
- Johns Hopkins University School of MedicineClass of 1995
Certifications & Licensure
- MD State Medical License 1998 - 2024
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Member American Society for Clinical Investigation, 2013
- Fellow (FACP) American College of Physicians, 2006
- Fellow Infectious Diseases Society of America
Publications & Presentations
PubMed
- Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.Han-Sol Park, Anna Yin, Caelan Barranta, John S Lee, Christopher A Caputo, Jaiprasath Sachithanandham, Maggie Li, Steve Yoon, Ioannis Sitaras, Anne Jedlicka, Yolanda E...> ;JCI Insight. 2024 Mar 14
- The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.Althoff, K., Stewart, C., Humes, E., Gerace, L., Boyd, C., Gebo, K., Justice, A., Hyle, E., Coburn, S., Lang, R., Silverberg, M., Horberg, M., Lima, V., Gill, M., Karr...> ;Plos Medicine. 2024 Jan 1
- 1 citationsOutpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.Han-Sol Park, Anna Yin, Caelan Barranta, John S Lee, Christopher A Caputo, Jaiprasath Sachithanandham, Maggie Li, Steve Yoon, Ioannis Sitaras, Anne Jedlicka, Yolanda E...> ;Medrxiv. 2023 Dec 15
- Join now to see all
Press Mentions
- Paxlovid OK for Use in Pregnant Women Infected with COVIDDecember 2nd, 2022
- Pregnant People Can Safely Take Paxlovid to Reduce the Possibility of Severe COVID-19, Study ShowsNovember 30th, 2022
- 5 Unusual Covid Symptoms — and What to Do About ThemNovember 16th, 2022
- Join now to see all
Grant Support
- Research Training In Microbial DiseasesNational Institute Of Allergy And Infectious Diseases2008–2011
- Clinical Outcomes In Elderly HIV PatientsNational Institute On Aging2006–2007
- Improving Health Care Utilization In HIV+ Drug UsersNational Institute On Drug Abuse2001–2005
Professional Memberships
- Fellow
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/kelly-gebo
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: